Literature DB >> 23791646

Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-β.

Tadaomi Kawashima1, Akemi Kosaka, Huimin Yan, Zijin Guo, Ryosuke Uchiyama, Ryutaro Fukui, Daisuke Kaneko, Yutaro Kumagai, Dong-Ju You, Joaquim Carreras, Satoshi Uematsu, Myoung Ho Jang, Osamu Takeuchi, Tsuneyasu Kaisho, Shizuo Akira, Kensuke Miyake, Hiroko Tsutsui, Takashi Saito, Ikuko Nishimura, Noriko M Tsuji.   

Abstract

The small intestine harbors a substantial number of commensal bacteria and is sporadically invaded by pathogens, but the response to these microorganisms is fundamentally different. We identified a discriminatory sensor by using Toll-like receptor 3 (TLR3). Double-stranded RNA (dsRNA) of one major commensal species, lactic acid bacteria (LAB), triggered interferon-β (IFN-β) production, which protected mice from experimental colitis. The LAB-induced IFN-β response was diminished by dsRNA digestion and treatment with endosomal inhibitors. Pathogenic bacteria contained less dsRNA and induced much less IFN-β than LAB, and dsRNA was not involved in pathogen-induced IFN-β induction. These results identify TLR3 as a sensor to small intestinal commensal bacteria and suggest that dsRNA in commensal bacteria contributes to anti-inflammatory and protective immune responses.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23791646     DOI: 10.1016/j.immuni.2013.02.024

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  83 in total

Review 1.  Modulation of autoimmune rheumatic diseases by oestrogen and progesterone.

Authors:  Grant C Hughes; Divaker Choubey
Journal:  Nat Rev Rheumatol       Date:  2014-08-26       Impact factor: 20.543

2.  PRDM16 represses the type I interferon response in adipocytes to promote mitochondrial and thermogenic programing.

Authors:  Megan Kissig; Jeff Ishibashi; Matthew J Harms; Hee-Woong Lim; Rachel R Stine; Kyoung-Jae Won; Patrick Seale
Journal:  EMBO J       Date:  2017-04-13       Impact factor: 11.598

Review 3.  A long-distance relationship: the commensal gut microbiota and systemic viruses.

Authors:  Emma S Winkler; Larissa B Thackray
Journal:  Curr Opin Virol       Date:  2019-06-18       Impact factor: 7.090

4.  Salmonella Typhimurium Co-Opts the Host Type I IFN System To Restrict Macrophage Innate Immune Transcriptional Responses Selectively.

Authors:  Darren J Perkins; Rajesh Rajaiah; Sharon M Tennant; Girish Ramachandran; Ellen E Higginson; Tristan N Dyson; Stefanie N Vogel
Journal:  J Immunol       Date:  2015-07-22       Impact factor: 5.422

Review 5.  Innate immunity: actuating the gears of celiac disease pathogenesis.

Authors:  Sangman Michael Kim; Toufic Mayassi; Bana Jabri
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-05-11       Impact factor: 3.043

Review 6.  Immunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity.

Authors:  Celia Escudero-Hernández; Amado Salvador Peña; David Bernardo
Journal:  Curr Gastroenterol Rep       Date:  2016-07

Review 7.  Interplay between DNA repair and inflammation, and the link to cancer.

Authors:  Dawit Kidane; Wook Jin Chae; Jennifer Czochor; Kristin A Eckert; Peter M Glazer; Alfred L M Bothwell; Joann B Sweasy
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-01-13       Impact factor: 8.250

Review 8.  Host-microbiota interactions in immune-mediated diseases.

Authors:  William E Ruff; Teri M Greiling; Martin A Kriegel
Journal:  Nat Rev Microbiol       Date:  2020-05-26       Impact factor: 60.633

Review 9.  The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders.

Authors:  Urdhva Raval; Joyce M Harary; Emma Zeng; Giulio M Pasinetti
Journal:  Expert Rev Neurother       Date:  2020-06-27       Impact factor: 4.618

Review 10.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.